Vice President Clinical Operations previously assistant vice president psychopharmacologic drug development at Wyeth Research where he oversaw more than 15 global neuroscience drug development programs and served as a representative of the Neuroscience Leadership Team responsible for establishing the business strategy for neuroscience drug development from early development through life cycle management programs. For more than 20 years he also held positions of increasing responsibilities in clinical research and development with the American Cyanamid Company and Hoffmann-LaRoche Inc. He has published more than 145 scientific articles books abstracts and poster presentations in the areas of neuropharmacology neurobiology neuroscience and psychiatric disorders. He is a member of the Society for Neuroscience and the American Association for the Advancement of Science. Dr. Mangano earned his Ph.D. in BioChemistry from Fordham University. |